Scientific work

Dr. Öğr. Ü. Mert Öztaş

22 publications. The source of the information is stated next to each publication.

Back to profile

  1. Impact of SAA versus CRP in evaluation of acute-phase response in familial Mediterranean fever

    Medicine, 2026

    DOI 10.1097/md.0000000000050309 PMID 42629676 Open-access full textSource: OpenAlex

  2. Musculoskeletal Manifestations in Behçet’s Syndrome

    Springer eBooks, 2025

    DOI 10.1007/978-3-031-77251-1_14 Source: OpenAlex

  3. Rituximab in the management of retroperitoneal fibrosis: A single tertiary rheumatology care center experience

    International Journal of Rheumatic Diseases, 2023

    DOI 10.1111/1756-185x.14798 PMID 37358327 2 citations (Europe PMC) Source: OpenAlex

  4. Frequency and severity of COVID‐19 in patients with various rheumatic diseases treated regularly with colchicine or hydroxychloroquine

    Journal of Medical Virology, 2022

    DOI 10.1002/jmv.27731 PMID 35315100 5 citations (Europe PMC) Open-access full textSource: OpenAlex

  5. Antibody responses to inactivated and mRNA SARS-CoV-2 vaccines in familial Mediterranean fever patients treated with interleukin-1 inhibitors

    Rheumatology, 2022

    DOI 10.1093/rheumatology/keac123 PMID 35258567 3 citations (Europe PMC) Open-access full textSource: OpenAlex

  6. Willingness to get the COVID-19 vaccine among patients with rheumatic diseases, healthcare workers and general population in Turkey: a web-based survey

    Rheumatology International, 2021

    DOI 10.1007/s00296-021-04841-3 PMID 33779780 82 citations (Europe PMC) Open-access full textSource: OpenAlex

  7. Antibody response to inactivated COVID-19 vaccine (CoronaVac) in immune-mediated diseases: a controlled study among hospital workers and elderly

    Rheumatology International, 2021

    DOI 10.1007/s00296-021-04910-7 PMID 34109466 68 citations (Europe PMC) Open-access full textSource: OpenAlex

  8. The incidence, clinical characteristics, and outcome of COVID-19 in a prospectively followed cohort of patients with Behçet’s syndrome

    Rheumatology International, 2021

    DOI 10.1007/s00296-021-05056-2 PMID 34825278 8 citations (Europe PMC) Open-access full textSource: OpenAlex

  9. Presentation characteristics and clinical outcome of patients with giant cell arteritis followed by a single center

    TURKISH JOURNAL OF MEDICAL SCIENCES, 2021

    DOI 10.3906/sag-2102-263 PMID 36326373 2 citations (Europe PMC) Open-access full textSource: OpenAlex

  10. Efficacy and Safety of Imatinib Treatment in Elderly Patients With Chronic Myeloid Leukemia: Real-Life Data and a Single-Center Experience

    Clinical Lymphoma Myeloma & Leukemia, 2021

    DOI 10.1016/j.clml.2021.04.005 PMID 34052176 6 citations (Europe PMC) Source: OpenAlex

  11. Haemophagocytic lymphohistiocytosis in a patient with familial Mediterranean fever and miliary tuberculosis: a case report

    Modern Rheumatology Case Reports, 2021

    DOI 10.1093/mrcr/rxab026 PMID 34549298 1 citation (Europe PMC) Open-access full textSource: OpenAlex

  12. Changing the traditional p-value significance threshold to .005 does not decrease the number of statistically significant p-values in observational studies more than in randomised controlled trials

    Clinical and Experimental Rheumatology, 2021

    DOI 10.55563/clinexprheumatol/smg1bu PMID 33253087 Source: OpenAlex

  13. Concerns Regarding the Analysis of a Takayasu Arteritis Cohort: Comment on the Article by Goel et al

    Arthritis & Rheumatology, 2021

    DOI 10.1002/art.41784 PMID 33982898 Source: OpenAlex

  14. Characteristics and outcomes of Behçet’s syndrome patients with Coronavirus Disease 2019: a case series of 10 patients

    Internal and Emergency Medicine, 2020

    DOI 10.1007/s11739-020-02427-8 PMID 32647946 19 citations (Europe PMC) Open-access full textSource: OpenAlex

  15. Giant Cell Arteritis with Concomitant Chronic Myelomonocytic Leukemia

    Turkish Journal of Hematology, 2020

    DOI 10.4274/tjh.galenos.2020.2020.0357 PMID 32702949 1 citation (Europe PMC) Open-access full textSource: OpenAlex

  16. A Rare Cause of AA Amyloidosis

    JCR Journal of Clinical Rheumatology, 2020

    DOI 10.1097/rhu.0000000000001613 PMID 33298821 Source: OpenAlex

  17. Evaluation of the follow-up and drug-related side effects of bosentan treatment for the treatment of systemic sclerosis related digital ulcer: a real life experience

    Ulusal Romatoloji Dergisi, 2020

    DOI 10.4274/raed.galenos.2020.97269 Source: OpenAlex

  18. AB1097 RETROPERITONEAL FIBROSIS- A SINGLE CENTER EXPERIENCE

    Annals of the Rheumatic Diseases, 2019

    DOI 10.1136/annrheumdis-2019-eular.7266 Source: OpenAlex

  19. Atorvastatin-induced dermatomyositis

    Rheumatology International, 2017

    DOI 10.1007/s00296-017-3658-9 PMID 28238074 12 citations (Europe PMC) Source: OpenAlex

  20. Real-Life Data and a Single Center Experience on the Efficacy and Toxicity Profile of Imatinib in the Treatment of Elderly Patients with Chronic Myeloid Leukemia

    Blood, 2016

    DOI 10.1182/blood.v128.22.1905.1905 Source: OpenAlex

  21. Frequency and severity of COVID-19 in patients with various rheumatic diseases treated regularly with colchicine or hydroxychloroquine.

    Source: acibadem.com.tr profile page

  22. Atorvastatin-induced dermatomyositis.

    Source: acibadem.com.tr profile page